Search Results 71-80 of 16291 for pharmacogenetics
About this study. This research is being done to better understand how genetic information related to drug dosing and use can affect medical care of ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
... pharmacogenetics component of this study. Refusal to give consent for this component does not exclude a participant from participation in this clinical ...
The purpose of this study is perform HOUSES index analysis on 500 patients with a first-degree relative diagnosed with pancreatic cancer to see if there is a ...
Faculty and staff of the Pharmacogenomics Lab of Richard Weinshilboum, M.D., at Mayo Clinic's campus in Rochester, Minnesota.
This research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery.
The purpose of this study is to provide descriptive information on patients with hereditary hemochromatosis, including their predominant symptoms, time to ...
The aim of this research study is to develop and validate several clinical molecular genetic lab tests for the confirmation of biochemical genetic test results.
5X Challenge is here! 5X My Gift! Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19. 5X My Gift!
In this procedure, specialists aim to fix or replace a faulty gene to try to cure a disease or make the body better able to fight a disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.